Moderna: Covid vaccine shows nearly 95% protection

Moderna's coronavirus vaccine is 94.5% effective, ac...

武漢肺炎疫苗試驗再報佳音 莫德納防護力近95% | 國際 | 重點新聞 | 中央社 CNA

mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: Moderna’s COVID-19 Vaccine Candidate Meets its Prima...